GWM
DCPH

Geneos Wealth Management’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Geneos Wealth Management’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,000
Closed -$9K – 3026
2021
Q4 		$9K Sell
1,000
-1,050
-51% -$19.7K ﹤0.01% 2243
2021
Q3 		$70K Sell
2,050
-100
-5% -$3.19K ﹤0.01% 1333
2021
Q2 		$78K Buy
2,150
+500
+30% +$19.4K ﹤0.01% 1269
2021
Q1 		$76K Hold
1,650
– – ﹤0.01% 1419
2020
Q4 		$72K Buy
1,650
+400
+32% +$23.7K ﹤0.01% 1279
2020
Q3 		$62K Sell
1,250
-100
-7% -$4.9K ﹤0.01% 1159
2020
Q2 		$77K Buy
1,350
+200
+17% +$10.7K ﹤0.01% 1032
2020
Q1 		$48K Buy
1,150
+200
+21% +$11.1K ﹤0.01% 1131
2019
Q4 		$61K Buy
950
+150
+19% +$7.13K ﹤0.01% 1158
2019
Q3 		$26K Sell
800
-1,140
-59% -$33.7K ﹤0.01% 1495
2019
Q2 		$43K Buy
1,940
+550
+40% +$12.9K ﹤0.01% 1277
2019
Q1 		$32K Buy
1,390
+250
+22% +$6.54K ﹤0.01% 1366
2018
Q4 		$23K Buy
1,140
+470
+70% +$11.6K ﹤0.01% 1449
2018
Q3 		$25K Buy
+670
New +$24.8K ﹤0.01% 1489
2018
Q1 		– Sell
-300
Closed -$6K – 2249
2017
Q4 		$6K Buy
+300
New +$5.88K ﹤0.01% 1791

Other funds holding DCPH

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Geneos Wealth Management's DCPH Position: Q1 2022 in Review

Geneos Wealth Management sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q1 2022, closing a stake of 1,000 shares — an estimated $9K sold.

Geneos Wealth Management first reported a position in DCPH in Q4 2017 and held it in 15 quarters. The position peaked at $78K in Q2 2021. 123 funds tracked by Wall St. Rank hold DCPH as of Q1 2022.

  • Geneos Wealth Management reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Geneos Wealth Management sold 1,000 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q1 2022, an estimated $9K.
  • Geneos Wealth Management first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q4 2017 and held it in 15 quarters.
  • Geneos Wealth Management's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $78K in Q2 2021.
  • 123 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q1 2022.

Based on Geneos Wealth Management's 13F filing for Q1 2022, filed 16 May 2022.